串联病变取栓联合急诊颈动脉支架术后收缩压峰值与症状性颅内出血的相关性
回顾性多中心队列纳入217例前循环串联病变接受机械取栓联合急诊颈动脉支架的患者,评估术后48小时内反复收缩压峰值与症状性颅内出血的关联。结果显示无已知高血压患者中术后收缩压峰值独立增加症状性颅内出血风险,而已知高血压患者中该关联不显著。该发现为探索性结果,需前瞻性研究进一步验证。
要点
- 无已知高血压患者术后收缩压峰值>140 mm Hg需警惕症状性颅内出血风险增加
- 已知高血压患者术后收缩压峰值与症状性颅内出血的关联不显著
- 症状性颅内出血患者90天预后极差,15例中11例死亡、4例mRS为5分
核心结论
- 术后48小时内反复收缩压峰值与串联病变取栓联合急诊颈动脉支架术后症状性颅内出血相关,尤其在无已知高血压患者中。
- 无已知高血压患者术后收缩压峰值与症状性颅内出血独立相关(调整OR=7.45;95%CI 1.39-39.79;P=.02)。
- 已知高血压患者术后收缩压峰值与症状性颅内出血无显著关联(调整OR=3.03;95%CI 0.61-15.20;P=.18)。
研究设计与样本
- 回顾性多中心队列研究,纳入2015年6月至2020年1月12家高容量卒中中心的前循环串联病变患者。
- 纳入标准为机械取栓联合急诊颈动脉支架治疗,排除术后无血压数据者后共217例,平均年龄71.0岁。
- 术后在卒中单元或重症监护室行有创动脉监测或每10分钟自动无创袖带测量。
- 主要暴露定义为术后48小时内反复收缩压>140 mm Hg,有创监测持续≥10分钟或≥2次连续袖带测量,排除护理相关升高。
关键影像表现/征象
- 217例患者中58例发生影像学出血转化,包括HI2、PH1和PH2。
- 217例患者中15例发生症状性颅内出血。
- 本次分析中的抗栓变量与症状性颅内出血的单变量关联均不显著。
诊断标准与关键数值
- 症状性颅内出血按ECASS III标准定义。
- 收缩压峰值定义为术后48小时内收缩压>140 mm Hg,有创监测持续≥10分钟或≥2次连续袖带测量,排除护理相关升高。
- 无已知高血压患者术后收缩压峰值的调整OR=7.45(95%CI 1.39-39.79;P=.02)。
- 已知高血压患者术后收缩压峰值的调整OR=3.03(95%CI 0.61-15.20;P=.18)。
- 症状性颅内出血患者90天随访:11/15死亡,4/15为改良Rankin量表5分。
临床应用与阅片要点
- 术后48小时内应连续监测收缩压,重视反复出现且持续≥10分钟或≥2次连续袖带测量的收缩压>140 mm Hg。
- 无已知高血压患者术后出现反复收缩压峰值时需高度警惕症状性颅内出血风险,并密切观察影像学变化。
- 血压升高与症状性颅内出血的时序关系尚不明确,解读时需考虑反向因果的可能,不能仅凭血压峰值判定出血已发生。
局限性
- 回顾性设计无法排除反向因果关系,即收缩压峰值可能继发于症状性颅内出血而非其前驱因素。
- 本次为探索性假设生成分析,需前瞻性研究并采用标准化时间戳血压、临床和影像数据加以验证。
- 抗栓变量分析显示无显著单变量关联,原文未报告多变量模型纳入的全部协变量细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Symptomatic intracranial hemorrhage remains a relevant complication after thrombectomy with emergent carotid stenting for tandem lesions. We assessed whether recurrent postprocedural systolic blood pressure peaks were associated with ECASS III symptomatic intracranial hemorrhage.
MATERIALS AND METHODS: This retrospective multicenter cohort included patients with anterior-circulation tandem lesions treated with mechanical thrombectomy plus emergent carotid stenting at 12 BLINDED FOR PEER REVIEW high-volume stroke centers between June 2015 and January 2020. Patients were continuously monitored on intermediate care, intensive care, or stroke units by invasive arterial monitoring or automated noninvasive measurements every 10 minutes. Primary exposure was recurrent postprocedural SBP >140 mm Hg within 48 hours, excluding care-related elevations, lasting ≥10 minutes during invasive monitoring or occurring in ≥2 consecutive cuff measurements.
RESULTS: After excluding patients without postprocedural blood pressure data, 217 patients were analyzed. Mean age was 71.0 years. Radiographic hemorrhagic transformation including HI2, PH1, and PH2 occurred in 58/217 patients, and symptomatic intracranial hemorrhage occurred in 15/217. Neither known hypertension nor admission hypertension was associated with symptomatic intracranial hemorrhage. Antithrombotic variables included in the present analysis showed no significant univariable association with symptomatic intracranial hemorrhage. In multivariable logistic regression, postprocedural systolic blood pressure peaks in patients without known hypertension were independently associated with symptomatic intracranial hemorrhage (adjusted OR, 7.45; 95% CI, 1.39-39.79; P=.02), whereas peaks in patients with known hypertension were not significantly associated with symptomatic intracranial hemorrhage (adjusted OR, 3.03; 95% CI, 0.61-15.20; P=.18). At 90-day follow-up, 11/15 patients with symptomatic intracranial hemorrhage had died, and the remaining 4/15 had a modified Rankin Scale score of 5.
CONCLUSIONS: Recurrent postprocedural systolic blood pressure peaks were associated with symptomatic intracranial hemorrhage after thrombectomy with emergent carotid stenting, particularly in patients without known hypertension. Reverse causality cannot be excluded; these hypothesis-generating findings warrant prospective evaluation with standardized time-stamped blood pressure, clinical, and imaging data.
引用
- Mann, Stahn, Bersch, et al. Association of Postprocedural Systolic Blood Pressure Peaks with Symptomatic Intracranial Hemorrhage after Thrombectomy with Emergent Carotid Stenting for Tandem Lesions: An Exploratory Multicenter Cohort Study. AJNR Am J Neuroradiol. 2026. PMID: 42498649. doi:10.3174/ajnr.A9544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。